INIS
central nervous system
20%
damage
60%
design
20%
diseases
100%
host
20%
humans
20%
immunotherapy
20%
in vivo
20%
induction
20%
mice
100%
molecules
20%
pathology
100%
probes
20%
proteolipids
80%
reactivity
20%
tissues
40%
tolerance
40%
Medicine and Dentistry
Active Immunization
9%
Acute Disease
27%
Autoimmune Disease
9%
Cells
18%
Central Nervous System
9%
Delayed Hypersensitivity
9%
Development
9%
Diseases
9%
Epitope
100%
Experimental Autoimmune Encephalomyelitis
36%
Host
9%
Human
9%
Hypersensitivity Response
9%
Immunological Tolerance
9%
Immunopathogenesis
9%
Immunotherapy
9%
Pathology
100%
Recurrent Disease
9%
Splenic T Cell
9%
T Cell
27%
T-Cell Response
9%
Therapeutic Procedure
9%
Tissue Injury
18%
Biochemistry, Genetics and Molecular Biology
Development
20%
Host
20%
Human
20%
Immunological Tolerance
20%
Molecule
20%
Mouse
80%
Probe
20%
Swiss James Lambert Mouse
20%
T Cell
100%
Immunology and Microbiology
Active Immunization
9%
Autoimmune Disease
9%
Cells
18%
Central Nervous System
9%
Delayed Hypersensitivity
9%
Development
9%
Experimental Autoimmune Encephalomyelitis
36%
Host
9%
Human
9%
Immune Tolerance
9%
Immunopathogenesis
9%
Immunotherapy
9%
Molecule
9%
Mouse
36%
Splenic T Cell
9%
Swiss James Lambert Mouse
9%
Tissues
18%
Neuroscience
Active Immunization
9%
Autoimmune Disease
9%
Epitope
100%
Experimental Autoimmune Encephalomyelitis
36%
Immunotherapy
9%
In Vivo
9%
Proteolipid
36%